Amar Gajjar, MD

Amar Gajjar, M.D., specializes in the treatment of infants, children and teenagers with malignant tumors of the brain and spine at St. Jude Children’s Research Hospital, which is home to one of the largest clinical research brain tumor programs in North America. Gajjar joined St. Jude in 1989 to finish training as a pediatric oncologist. Today he co-chairs the St. Jude Department of Oncology, directs the institution’s Neuro-Oncology Division and is co-leader of the hospital’s Neurobiology and Brain Tumor Program. Through that program, Gajjar works with scientists to develop medications for the treatment of brain tumors. He also holds the Scott and Tracie Hamilton Endowed Chair in Brain Tumor Research. Gajjar chairs the brain tumor committee in the Children’s Oncology Group and is a member of American Society of Clinical Oncology and the American Society of Pediatric Hematology Oncology. He is the principal investigator of SJMB12, a multi-institution clinical trial organized by St. Jude that is now underway for treatment of children and teenagers newly identified with medulloblastoma. Medulloblastoma is the most common malignant brain tumor in young people.